Sort
78,016 grants matching “breast cancer”
INVESTIGATING THE THERAPEUTIC POTENTIAL OF THE ILEI/LIFR PATHWAY IN METASTATIC BREAST CANCER
$447,521The Medical University Of South Carolina · · FY2018 · Department of the Army
Chemical Tools for Studying Fucosylated Glycans
$447,518Peng Wu · Scripps Research Institute, The · R01 · FY2019 · GM
Chemical Tools for Studying Fucosylated Glycans
$447,518Peng Wu · Scripps Research Institute, The · R01 · FY2017 · GM
Convolutional Neural Network for Disease Prediction, Biomarker Discovery, and Validation in Alzheimer's Disease
$447,509Jingchun Chen · University Of Nevada Las Vegas · R15 · FY2024 · AG
Prevalence effects in visual research: Theoretical and practical implications
$447,500Jeremy M Wolfe · Brigham And Women'S Hospital · R01 · FY2020 · EY
Characterizing a Common Degradation Pathway for Nuclear Hormone Receptors
$447,500Jonathan Michael Tsai · Brigham And Women'S Hospital · DP5 · FY2025 · OD
Characterizing a Common Degradation Pathway for Nuclear Hormone Receptors
$447,500Jonathan Michael Tsai · Brigham And Women'S Hospital · DP5 · FY2023 · OD
Regulation of APOBEC3 cytidine deaminase-induced mutation during cancerdevelopment
$447,500Steven A Roberts · University Of Vermont & St Agric College · R01 · FY2024 · CA
Characterizing a Common Degradation Pathway for Nuclear Hormone Receptors
$447,500Jonathan Michael Tsai · Brigham And Women'S Hospital · DP5 · FY2024 · OD
Prevalence effects in visual research: Theoretical and practical implications
$447,500Jeremy M Wolfe · Brigham And Women'S Hospital · R01 · FY2023 · EY
Tumor cell -TAM Paracrine Signaling in Breast Cancer
$447,481Elizabeth S. Yeh · Indiana University Indianapolis · R01 · FY2025 · CA
Developmental Funds
$447,466Joann B Sweasy · University Of Arizona · P30 · FY2022 · CA
Ponce School of Medicine - Moffitt Cancer Center Partnership
$447,454Warren Jackson Pledger · H. Lee Moffitt Cancer Ctr & Res Inst · U56 · FY2008 · CA
PROGRAMMABLE MOLECULAR SENSORS FOR THE DESIGN OF INTELLIGENT THERAPEUTICS TARGETED TO BREAST CANCER CELLS
$447,438The Leland Stanford Junior University · · FY2008 · Department of the Army
Methodologic Innovations in Cancer Epidemiology
$447,434Bernard A. Rosner · Brigham And Women'S Hospital · R01 · FY2025 · CA
Combined magnetophoresis and photodynamic therapy for the treatment of TNBC
$447,426Andrew Tsourkas · University Of Pennsylvania · R01 · FY2021 · EB
Combined magnetophoresis and photodynamic therapy for the treatment of TNBC
$447,426Andrew Tsourkas · University Of Pennsylvania · R01 · FY2022 · EB
Combined magnetophoresis and photodynamic therapy for the treatment of TNBC
$447,426Andrew Tsourkas · University Of Pennsylvania · R01 · FY2023 · EB
Systems Bioengineering of Cancer Cell Migration
$447,397Gary D Luker · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Age-related shifts in epithelial lineages and tissue homeostasis in mammary gland
$447,385Mark A Labarge · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2013 · AG
Cancer and Leukemia Group B - The Ohio State University
$447,372Clara D Bloomfield · Ohio State University · U10 · FY2013 · CA
Defining the role of macropinocytosis in solid tumor growth and therapeutic resistance
$447,367Aimee L Edinger · University Of California-Irvine · R01 · FY2023 · CA
Epigenetic dependencies and vulnerabilities in endocrine-resistant breast cancer
$447,340Lluis Morey · University Of Miami School Of Medicine · R01 · FY2025 · CA
Role of the lncRNA BORG in Breast Cancer Metastatic Progression and Recurrence
$447,306William Schiemann · Case Western Reserve University · R01 · FY2022 · CA
Role of the lncRNA BORG in Breast Cancer Metastatic Progression and Recurrence
$447,306William Schiemann · Case Western Reserve University · R01 · FY2023 · CA